Staidson (Beijing) Biopharmaceuticals Co., Ltd

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Study to Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients With Oligozoospermia and/or Asthenozoospermia.	Oligozoospermia and/or Asthenozoospermia	Not yet recruiting	Phase 2	2026-09-22	NCT07833943
BDB-001 Phase III Trial in ANCA-Associated Vasculitis	Skin and Connective Tissue Diseases, anti-neutrophil cytoplasmic antibody-associated vasculitis, autoimmune disease, cardiovascular disorder, immune system disorder, necrotizing vasculitis, skin disorder, skin vascular disease, vascular disorder, vasculitis	Recruiting	Phase 3	2026-08-13	NCT07168161
A Study to Evaluate the Safety and Tolerability of Single and Multiple Dose of STSP-0902 in Healthy Subjects	Genital Diseases, Male Urogenital Diseases, Urogenital Diseases, infertility disorder, male infertility, male reproductive system disorder, oligospermia	Recruiting	Phase 1	2026-05-22	NCT06948799
A Phase II Study of STSP-0902 Ophthalmic Solution in Patients With Neurotrophic Keratitis	neurotrophic keratopathy	Recruiting	Phase 2	2026-04-07	NCT06975748
To Evaluate The Safety and Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome	Respiration Disorders, adult acute respiratory distress syndrome, lung disorder, respiratory system disorder	Recruiting	Phase 3	2026-01-02	NCT07208591

Clinical trials